000 | 01329 a2200361 4500 | ||
---|---|---|---|
005 | 20250513051017.0 | ||
264 | 0 | _c19950427 | |
008 | 199504s 0 0 eng d | ||
022 | _a0160-2446 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRosenthal, J | |
245 | 0 | 0 |
_aNilvadipine: profile of a new calcium antagonist. An overview. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology _c1994 |
||
300 |
_aS92-107 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacokinetics |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacokinetics |
650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscle Relaxation _xdrug effects |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aNifedipine _xanalogs & derivatives |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 24 Suppl 2 _gp. S92-107 |
|
999 |
_c7897434 _d7897434 |